Original Research
Published on 21 Oct 2024
The potential role of next-generation sequencing in identifying MET amplification and disclosing resistance mechanisms in NSCLC patients with osimertinib resistance
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1470827
- 3,544 views
- 2 citations